[DOI] [PMC free article] [PubMed] [Google Scholar] 25.Varriale E., Ferrante A., Crocetto F., Cianciulli M.R., Palermo E., Vitale A., Benincasa G
Researchers often investigate these peptides in cell culture systems that analyze fibroblast activity, endothelial cell migration, and extracellular matrix organization
By bridging the gap between preclinical insight and clinical validation, we can advance toward a new era of precision immunometabolism therapy, ultimately improving long-term outcomes for patients with autoimmune diseases
Enter Cagrilintide, a long-acting amylin analog peptide developed by Novo Nordisk
Exp Neurobiol 2015
doi: 10.1128/JB.183.18.5385-5394.2001 16 ChangY